reported that the CCR4 antagonist AZD2098 significantly inhibited the promotive effect of TAM-derived CCL17 on the proliferation, invasion and migration of the PA cell line GH3 in vitro and reduced tumor burden in GH3 tumor-bearing mice in vivo (35). This evidence concerns the gene CCR4 and neoplasm.